Company intelligence / Profile preview

Life Detection Technologies

Santa Clara, California, United Statesdistasense.com ↗

Ownership: Private
Development stage: Commercial

Overview

Life Detection Technologies has developed a proprietary, machine learning-driven platform that continuously monitors vital signs to anticipate and reduce the severity of COPD exacerbations. The company’s solution is designed to enable proactive intervention in chronic care management. No published clinical trial results are available; the product appears to be commercially available or piloted with healthcare providers[1][4][5].

Therapeutic areas: PulmonologyOther
Modalities: DeviceDigital biomarker platformMachine learning-based monitoring system
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Life Detection Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Life Detection Technologies.

Explore the full profile